Drs. Christy Capone, Erica Eaton, and Carolina Haass-Koffler have received funding from the OVPR and the CADRE to conduct the first pilot trial of psychedelics at CAAS, under a grant entitled "Safety, feasibility, and acceptability of MDMA-assisted therapy for the treatment of co-occurring alcohol use disorders and posttraumatic stress disorder in veterans."
Dr. David Zelaya has been appointed to the American Psychological Association Board for Scientific Affairs Work Group for Journal Reporting Guidelines for Equity, Diversity, Inclusion, and Justice in Psychological Science.
Researchers at JCOIN’s Brown University Clinical Research Center (MPIs: Rosemarie Martin, PhD, Damaris Rohsenow, PhD), developed the Prescription Drug Abuse Policy System (PDAPS). This online resource provides data and information on state policies and laws aimed at responding to substance use disorders, including topics related to justice-involved populations, naloxone access, medication for opioid use disorder (MOUD), prescription drug monitoring programs, and more.
CAAS Senior Research Assistant Jake Tempchin will matriculate this fall at the University of Memphis in pursuit of a PhD in clinical psychology. He will study with Dr. Jim Murphy, focusing on behavioral economics, motivational interviewing, and the implementation of interventions to reduce harms experienced from substance use.
